The performance of companies tied to flagship drugs like Viagra presents a nuanced investment scenario . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the patent expiration in key markets has introduced considerable risk . Investors are now assessing the consequences of generic comp